Matthew Morgan

Total Brain Ltd. engages in the the development and sale of brain health products. The company was founded by Evian Gordon and Dan Segal in 2000 and is headquartered in Sydney, Australia.

3D Medical Ltd. engages in the manufacturing and distributing of safety syringe products. The company is involved in the research and development of medical syringe technology and mineral exploration. Its products include Medical 3D Printing, Enterprise Imaging Platform, Holographic Workstation, Theatre Motion Control and Big Data. The company was founded by John Riemelmoser on January 20, 1977 and is headquartered in Port Melbourne, Australia.

Diversa Pty Ltd. engages in the provision of investment management and financial services. It operates through Superannuation Services and Trustee Services segments. The Superannuation Services segment provides administration and promotion services to superannuation funds and the issue of group risk products. The Trustee Services segment involves in the third party superannuation trustee services and investment services. The company was founded by Matthew Morgan and Angus Craig on July 03, 1997 and is headquartered in Melbourne, Australia.

Queensland BioCapital Funds Pty Ltd. (QBF) is the venture capital arm of Queensland Investment Corporation, a Queensland Government-owned corporation. QBF established in 2002, located in Australia.

Xbio Systems provides integrated software solutions for the global Life Sciences sector. Their solutions have been designed to reduce business risk, improve governance and regulatory compliance, increase user acceptance, maximize operational control and reduce the cost of IT. At the center of each solution is the Xbio platform that automates workflows and provides advanced content management within a secure, web-based environment. By combining these two basic building blocks, Xbio's clients are able to make significant and material differences to cycle times and operational costs, with clients regularly reporting productivity improvements in excess of 40%. The platform also helps clients to avoid the high sunk costs typically associated with Life Sciences IT solutions. Customers have the option of deploying the software internally or entering into a managed services arrangement. Software modules can also be purchased or subscribed to as and when they are required and turned off to reduce costs when development changes. The open architecture of the platform allows for ready integration with existing IT solutions. During deployment, the workflows, templates, access rights and toolsets can be designed and configured to support customer business processes and subsequently maintained in-house across all related activities in the drug development lifecycle.

Relevare Aust Pty Ltd. develops innovative methods to treat diseases. The company was founded on August 9, 2004 and is headquartered in Abbotsford, Australia.